Mimetas is a biotechnology company developing human organon-a-chip tissue models for testing drugs, chemicals and food components in OrganoPlates®. The company develops and validates customized disease, toxicology and transport models and ultimately will make its technology available for personalized therapy selection. Mimetas’ unique microfluidic technology and model development know-how enables testing of compounds in high- throughput, showing better predictivity as compared to laboratory animals and conventional cell culture models.